Related references
Note: Only part of the references are listed.Vitamin D deficiency: a potential risk factor for cancer in obesity?
Silvia Migliaccio et al.
INTERNATIONAL JOURNAL OF OBESITY (2022)
Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment
Zisheng Kang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Liyang Fei et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Vitamin D Signaling Pathway
Marco Fraga et al.
FRONTIERS IN IMMUNOLOGY (2021)
Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Maosen Xu et al.
CELL PROLIFERATION (2021)
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
Suguru Kadomoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of chemokine receptors in thyroid cancer and immunotherapy
Francesca Coperchini et al.
ENDOCRINE-RELATED CANCER (2019)
Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment
Xu Wu et al.
ACTA PHARMACEUTICA SINICA B (2019)
CCL2 is Modulated by Cytokines and PPAR-gamma in Anaplastic Thyroid Cancer
Silvia Martina Ferrari et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Role of Chemokines in Thyroid Cancer Microenvironment: is CXCL8 the Main Player?
Mario Rotondi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
Kun-Yu Teng et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The Role of Vitamin D in Thyroid Diseases
Dohee Kim
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status
Mingyang Song et al.
GUT (2016)
The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
Carmela Passaro et al.
ONCOTARGET (2016)
1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest
Wen Peng et al.
ENDOCRINE RESEARCH (2016)
Vitamin D and the Epithelial to Mesenchymal Transition
Maria Jesus Larriba et al.
STEM CELLS INTERNATIONAL (2016)
1α,25(OH)2D3 Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition
Yong-Feng Hou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential
Kun-Chun Chiang et al.
CANCER LETTERS (2015)
Mechanistic Effects of Calcitriol in Cancer Biology
Lorenza Diaz et al.
NUTRIENTS (2015)
A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089
Khushboo Sharma et al.
AUTOPHAGY (2014)
Increased CYP24A1 expression is associated with BRAFV600E mutation and advanced stages in papillary thyroid carcinoma
Minjing Zou et al.
CLINICAL ENDOCRINOLOGY (2014)
The role of the inflammatory microenvironment in thyroid carcinogenesis
Lucas Leite Cunha et al.
ENDOCRINE-RELATED CANCER (2014)
Low Serum 25-Hydroxyvitamin D Concentrations Are Associated with Increased Risk for Melanoma and Unfavourable Prognosis
Benjamin Bade et al.
PLOS ONE (2014)
Low Serum 25 Hydroxyvitamin D Is Associated with Poor Clinicopathologic Characteristics in Female Patients with Papillary Thyroid Cancer
Ji Ryang Kim et al.
THYROID (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
The Anti-cancer Actions of Vitamin D
Kun-Chun Chiang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice
Mario Rotondi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions
Vittorio Abbonante et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Interferon-γ and Tumor Necrosis Factor-α Sustain Secretion of Specific CXC Chemokines in Human Thyrocytes: A First Step Toward a Differentiation between Autoimmune and Tumor-Related Inflammation?
Mario Rotondi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Hepatocellular carcinoma and vitamin D: A review
Kun-Chun Chiang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Vitamin D regulates the phenotype of human breast cancer cells
Natalia Pendas-Franco et al.
DIFFERENTIATION (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Vitamin D physiology
P. Lips
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)
1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis
Bo-Ying Bao et al.
CARCINOGENESIS (2006)
Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer
APB Dackiw et al.
ENDOCRINOLOGY (2004)
Share Paper
